Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE

(2015) Sharon M. Moe et al.   CIRCULATION

FGF-23 Is a Negative Regulator of Prenatal and Postnatal Erythropoiesis

(2014) Lindsay M. Coe et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Anemia and Thrombocytopenia Improves after Curative Parathyroidectomy in a Patient of Primary Hyperparathyroidism (PHPT)

(2012) Sanjay Kumar Bhadada et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Improved parathyroid hormone control by cinacalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal disease

(2011) M. Battistella et al.   CLINICAL NEPHROLOGY

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

(2011) Peter C. Austin   MULTIVARIATE BEHAVIORAL RESEARCH

Mineral and Bone Disorders Outcomes Study for Japanese Chronic Kidney Disease Stage 5D Patients: Rationale and Study Design

(2011) Shunichi Fukuhara et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Clinical Practice Guideline for the Management of Secondary Hyperparathyroidism in Chronic Dialysis Patients

(2009)   THERAPEUTIC APHERESIS AND DIALYSIS

Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy

(2008) Sanjay K. Bhadada et al.   CLINICAL ENDOCRINOLOGY

Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease

(2008) Sai Ram Keithi-Reddy et al.   KIDNEY INTERNATIONAL